Global Academy of Women's Cancer

Startseite
Deutschland
Neuenhagen
Global Academy of Women's Cancer

Kontaktinformationen, Karte und Wegbeschreibungen, Kontaktformulare, Öffnungszeiten, Dienstleistungen, Bewertungen, Fotos, Videos und Ankündigungen von Global Academy of Women's Cancer, Onkologe, Friedenstraße 58, Neuenhagen.

The Global Academy of Women´s Cancer was initiated by Andreas du Bois, Jonathan Ledermann, Sherko Kümmel and Peter Schmid, to offer a unique global training concept, with key opinion leaders in the fields of gynaecological oncology and breast cancer.

20/01/2026

Letzte Chance zur Teilnahme am führenden Brustkrebs-Webinar 2026.

In nur knapp zwei Stunden startet das Webinar der Global Academy of Women’s Cancer mit den wichtigsten klinischen Erkenntnissen aus ESMO, ASCO und SABCS 2025.

Führende Experten und Expertinnen fassen die entscheidenden Studien zusammen und ordnen sie praxisnah für Ihre tägliche Arbeit ein.

In zwei fokussierten Sessions erhalten Sie einen klaren, evidenzbasierten Überblick über aktuelle Entwicklungen beim frühen und fortgeschrittenen Mammakarzinom.

📌 Frühes Mammakarzinom mit Prof. Dr. Nadia Harbeck aus München
📌 Fortgeschrittenes Mammakarzinom mit Prof. Dr. Peter Schmid aus London

🕡 Start: Heute | 20.01.2026 von 18:30 bis 20:30 Uhr

🌐 Veranstalter:

Jetzt noch schnell online anmelden: https://lnkd.in/dehn9Gzj

20/01/2026

Letzte Chance zur Teilnahme am führenden Brustkrebs-Webinar 2026.
In nur knapp drei Stunden startet das Webinar der Global Academy of Women’s Cancer mit den wichtigsten klinischen Erkenntnissen aus ESMO, ASCO und SABCS 2025. Führende Experten und Expertinnen fassen die entscheidenden Studien zusammen und ordnen sie praxisnah für Ihre tägliche Arbeit ein.

In zwei fokussierten Sessions erhalten Sie einen klaren, evidenzbasierten Überblick über aktuelle Entwicklungen beim frühen und fortgeschrittenen Mammakarzinom.

📌 Frühes Mammakarzinom mit Prof. Dr. Nadia Harbeck aus München
📌 Fortgeschrittenes Mammakarzinom mit Prof. Dr. Peter Schmid aus London

🕡 Start: Heute in 4 Stunden | 20.01.2026 von 18:30 bis 20:30 Uhr

🌐 Veranstalter: MedConcept mbH

Jetzt noch schnell online anmelden: https://medconcept.swoogo.com/GAWC_Webinar_2026

16/01/2026

In this highlight, Prof. Dr. Hope S. Rugo, Director of Breast Oncology and the Women’s Cancers Program at City of Hope, discusses the latest breakthroughs in Antibody Drug Conjugates (ADCs).

Prof. Rugo dives into:
🧬 The newest data presented at ASCO 2025 and its application in real-world metastatic patient cases.

🧪 Managing the toxicity of ADCs proactively through prophylactic approaches and dose adjustments.

🫁 Specific insights on managing interstitial lung disease with Trastuzumab Deruxtecan.

🚀 The future of ADCs, including active trials in triple-negative and HER2-positive disease, and moving these treatments into early-stage settings.

The discussions at GAWC 2025 have been robust and forward-thinking, bridging the gap between clinical data and patient care.

Stay tuned for more highlights!

09/01/2026

In this session, Prof. Dr. Fotopoulou discusses the evolving landscape of surgical intervention for both advanced and relapsed ovarian cancer, focusing on two landmark data sets:

• The TRUST Study: A deep dive into the implications for clinical practice, emphasizing that the cornerstone of patient care remains high-maximal effort surgery performed within expert, accredited centers.

• SuROC-CON Data: An analysis of a significant multi-center study involving over 3,000 patients across five international centers (including MSK, Mayo Clinic, and Imperial). The data provides a “treasure” of information regarding prognostic factors and the surgical benefits across various histologies.

The discussion also explores how the surgical landscape is evolving in the era of PARP inhibitors, with full data from the SuROC-CON study expected to be published soon.

As we look forward to our next Meeting in Istanbul (January 30-31, 2026), we invite you to watch the full reel for these essential updates.

Stay tuned for more insights.

Learn more about GAWC: 🔗 global-academy-of-womens-cancer.org [LINK IN BIO]

31/12/2025

🎆 Happy New Year from the GAWC Team! 🎆
As we welcome 2026, we carry forward the same commitment that defines the Global Academy of Women’s Cancer: building a global platform where knowledge, innovation, and collaboration come together to improve care for women facing breast and gynecologic cancers.

From groundbreaking insights to real-world clinical discussions, our mission remains clear—to bridge the gap between science and practice, across disciplines and borders.

✨ Let’s start the year with purpose—and meet in person:
📍 GAWC 2026
🗓️ 30–31 January
📌 Istanbul, Türkiye

A new chapter, a new location, and a new opportunity to connect with leading experts and shape the future of oncology, together.

24/12/2025

🎄 Merry Christmas from the GAWC Team 🎄
As we come to a close of another inspiring year, we want to thank our incredible global community of clinicians, researchers, and partners committed to advancing women’s cancer care.

At the Global Academy of Women’s Cancer, we believe that collaboration, education, and innovation are the pillars of progress—and 2025 was a year filled with all three.

We’re especially grateful for the powerful discussions and shared knowledge at GAWC 2025 in Munich—and we’re already looking ahead with excitement!

🗓️ Save the date:
GAWC 2026 will take place on January 30–31, 2026, in Istanbul—a new location and a new time of year, but the same mission: to create a platform where early and advanced breast and gynecologic cancers are addressed together, across disciplines and borders.

Until then, may your holidays be filled with warmth, reflection, and the hope that drives all of us in this field.

❤️ With gratitude,
The GAWC Team

19/12/2025

Prof. Dr. Mansoor Raza Mirza from Copenhagen University Hospital shares exclusive insights from the 5th Global Academy of Women’s Cancer in Munich. 🇩🇪

As a leading expert in the field, Prof. Mirza contributed to three pivotal sessions focusing on the evolving landscape of Endometrial Cancer:
• Meet the Expert: A collaborative session on modern treatment strategies in a rapidly changing clinical landscape.
• The MMRp Debate: A data-driven discussion on whether all patients with mismatch repair proficient (MMRp) disease should be treated with immune checkpoint inhibitors.
• The PARP Inhibitor Controversy: Examining the role of PARP inhibitors in HRD-negative disease within first-line treatment.
🩺✨

📍 Looking ahead: We are thrilled to announce that the Global Academy of Women’s Cancer is heading to Istanbul next year!

Stay tuned for more expert highlights!

🔗 Visit the link in our bio for more information on our upcoming programs.

13/12/2025

What can we do to support patients struggling with the side effects of endocrine therapy?

In this insightful reel from GAWC 2025, Prof. Dr. Petra Voiß shares three evidence-based, non-pharmacological strategies to improve patient quality of life:

1️⃣ Acupuncture – supported by guidelines, it may alleviate joint pain, hot flashes, insomnia, and fatigue.
2️⃣ Mindfulness-Based Stress Reduction – shown to reduce hot flashes, fatigue, insomnia, and even fear of recurrence.
3️⃣ Exercise – with at least 2.5 hours of activity/week, patients may reduce fatigue, joint pain, and even lower recurrence risk.

These approaches are safe, empowering, and rooted in science.
✨ Have you or your patients tried any of them?

👉we look forward to seeing you at the next edition in Istanbul, Jan 30–31, 2026.

06/12/2025

Prof. Dr. Wolfgang Janni (University Hospital Ulm ) shares key takeaways from his talk on liquid biopsy in breast cancer at GAWC 2025.

In the metastatic setting, liquid biopsy is already part of routine clinical practice — helping identify predictive biomarkers such as PIK3CA and ESR1 mutations to guide therapy.

But what about early-stage breast cancer?
While not yet standard, ctDNA has shown strong potential to detect residual disease after primary treatment — and trials are ongoing for patients with molecular relapse. Results are expected soon.

📅 Don’t miss the next opportunity to be part of the conversation —
Join us in Istanbul, January 30–31, 2026 for the next Global Academy of Women’s Cancer.

27/11/2025

📣 Big news for the entire GAWC community!
The Global Academy of Women’s Cancer is changing both season and scenery in 2026!

🗓️ NEW DATES: January 30–31, 2026
📍 NEW LOCATION: Istanbul, Türkiye

We’re kicking off the new year from one of the world’s most vibrant cities.

Expect the same high-level faculty, interactive sessions, and open discussions — now set against the backdrop of Istanbul in winter. A new energy, a new chapter, but always the same commitment: to advancing women’s cancer care together.

Save the date and get ready for .
We can’t wait to welcome you.

20/11/2025

💡 How can we transform medical decision-making with AI?
In this GAWC Congress Highlight, Daniel Rüben— CEO of .ai — introduces a vision for a smarter future in women’s cancer care.

By integrating clinical guidelines, studies, and expert insights into a centralized AI-powered platform, Cancierge.ai aims to support specialists with evidence-based recommendations — and empower patients with validated second opinions.

🤝 At GAWC 2025 in Munich, we explored the frontiers of technology and care. See you in Istanbul for the next chapter.

12/11/2025

In this GAWC Congress Highlight, Prof. Dr. Michael Gnant (Medical University of Vienna) reflects on his keynote at , where he spoke about the importance of tailoring endocrine treatment to each patient’s individual risk profile.

With so many therapeutic options available today, personalization is key — and staying updated with evolving standards is crucial for every oncologist and researcher in the field.

📍Join us in Istanbul for GAWC 2026 and follow us to stay up-to-date!

Adresse

Friedenstraße 58
Neuenhagen
15366

Telefon

+4933424268913

Webseite

https://global-academy-of-womens-cancer.org/

Benachrichtigungen

Lassen Sie sich von uns eine E-Mail senden und seien Sie der erste der Neuigkeiten und Aktionen von Global Academy of Women's Cancer erfährt. Ihre E-Mail-Adresse wird nicht für andere Zwecke verwendet und Sie können sich jederzeit abmelden.